Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Molecular Medicine

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijmm.2012.1113PMID 22941199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pancreatic cancer.

  2013cited by this paper
• Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease

  2008cited by this paper
• Identification of Potential Markers for the Detection of Pancreatic Cancer Through Comparative Serum Protein Expression Profiling

  2007cited by this paper
• Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker.

  2007cited by this paper
• Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.

  2006cited by this paper
• Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma

  2006cited by this paper
• Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.

  2006cited by this paper
• Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum

  2006cited by this paper
• The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome.

  2006cited by this paper
• Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis

  2006cited by this paper
• Preclinical and post-treatment changes in the HCC-associated serum proteome

  2006cited by this paper
• The human plasma proteome: Analysis of Chinese serum using shotgun strategy

  2005cited by this paper
• Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.

  2005cited by this paper
• Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization‐time of flight (SELDI‐TOF) mass spectrometry: Multi‐institution correlation of spectra and identification of biomarkers

  2005cited by this paper
• Mass Spectrometry in Diagnostic Oncoproteomics

  2005cited by this paper
• Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling

  2005cited by this paper
• Possible detection of pancreatic cancer by plasma protein profiling.

  2005cited by this paper
• A pooled analysis of bone marrow micrometastasis in breast cancer.

  2005cited by this paper
• ROCR: visualizing classifier performance in R

  2005cited by this paper
• The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.

  2005cited by this paper
• SELDI‐TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma

  2005cited by this paper
• Prediction of Pancreatic Cancer by Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classification

  2005cited by this paper
• Pancreatic cancer

  2004cited by this paper
• Computational protein biomarker prediction: a case study for prostate cancer

  2004cited by this paper
• Diagnosis of pancreatic cancer using serum proteomic profiling.

  2004cited by this paper
• SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.

  2004cited by this paper
• Identification of gastric cancer patients by serum protein profiling.

  2004cited by this paper
• Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry

  2004cited by this paper
• Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

  2004cited by this paper
• Support vector machine classification on the web

  2004cited by this paper
• The Vision for a New Diagnostic Paradigm

  2003cited by this paper
• Counterpoint: The vision for a new diagnostic paradigm.

  2003cited by this paper
• Pancreatic cancer.

  2002cited by this paper
• Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.

  2002cited by this paper
• Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

  2002cited by this paper
• Epidemiology and risk factors

  2002cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Extraordinarily Elevated Ca19-9 in Benign Conditions: A Case Report and Review of the Literature

  2001cited by this paper
• Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients.

  2000cited by this paper
• Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.

  1999cited by this paper
• Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer.

  1989cited by this paper

• Role of artificial intelligence in the characterization of indeterminate pancreatic head mass and its usefulness in preoperative diagnosis

  2023cites this paper
• Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis

  2022cites this paper
• Artificial intelligence in pancreatic cancer

  2022cites this paper
• Lung Cancer and Mesothelioma

  2014cites this paper
• Advances in Proteomic Technologies and Its Contribution to the Field of Cancer

  2014cites this paper
• P-0157BIOMARKERS SCREENING BETWEEN PREOPERATIVE AND POSTOPERATIVE PATIENTS IN PANCREATIC CANCER

  2013cites this paper
• Biomarkers screening between preoperative and postoperative patients in pancreatic cancer.

  2013cites this paper